Unlocking the Value of Healthcare Innovation
Strong and growing economies are built by healthy and productive populations
The past century brought incredible progress in health. With innovative diagnostics and medicines, healthcare professionals now have powerful tools to prevent, diagnose, treat and manage disease, helping people to live longer and healthier lives.
But our collective efforts must continue. While living longer is a triumph, it presents a challenge: to maintain sustainable health systems at a time of ageing populations, increasing chronic diseases and with fewer working-age people. The pressure is mounting on our healthcare services, our collective well-being, and our economic future.
To build strong and growing economies, we need populations that are healthy and productive. But that won’t happen without action. We need to work together to invest in health systems that are ready for the innovations of today and tomorrow.
Perspectives and powerful moments that shape healthcare innovation
Tackling disease and boosting global productivity demands a bold shift: healthcare innovation must be seen as an investment, not a cost.
Healthcare innovation saves and extends lives
of life expectancy gains came from pharma innovation from 1990-2015.
(Health Affairs, PhRMA)
The burden of chronic disease is growing
of global deaths are from non-communicable diseases.
(2021 GBD Study)
The cost of poor health is growing too
burden by 2032 from MS, HER2+ cancer, and eye diseases – if we don’t act.
(WiFOR)
Good health means economic prosperity
could generate $2 to $4 in economic benefits.
(McKinsey, Prioritizing Health: A Prescription for Prosperity, 2020)
Innovation doesn’t always reach patients
of EU medicines were available to patients between 2020–2023.
(EFPIA W.A.I.T. Survey 2024)
Investing in innovation pays off
GDP gain from Roche’s HER2+ medicines (2017–2023).
(WifOR)
Investing in innovation pays off
GDP gain from our MS medicine.
(WifOR)
Only together can government and industry realise the value of innovation.
Demonstrating the value of innovation
[00:05]
[Speaker 1]
First, we need to realize the growing burden of noncommunicable diseases and the devastating cause they're bringing to not only patients, but to health systems and societies at large. So if we want to shift how we think about health care as opposed to a cause, but a strategic investment, we also have to start thinking about how we talk about it differently and how we measure the benefit of healthy society in relation to a healthy population. If you look at also the healthcare spend today, we often tend to look at it on the immediate outcome it has on a patient health outcome, but we need to be looking at that more broadly. What does it mean for the patient's quality of life? Can they go back to work? Can they continue work? What does that mean of them being a active member and contributor to society? So we really have to widen that lens. And simply said, strong economies, secure economies, need healthy and strong populations. So if we look at over the next decade, to educate the current innovation and the future innovation is going to drive massive advancement in how we manage disease today, from how we do better prevention to how we screen and treat and how we optimize the potential and the promise of artificial intelligence.
[01:20]
[Speaker 1]
This is why it's so essential that we invest in our healthcare today, but also in our innovation today so we can meet the needs of the future and secure not only health systems, but also our economies and our societies..